Assessment of effectiveness of oral vitamin D3 on Bacterial vaginosis in women in fertility ages
- Conditions
- Bacterial vaginosis.Acute vaginitis
- Registration Number
- IRCT201105096284N2
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 190
Ages 18-35; Stability in medical condition among 6 months later; Lack of Pathological obesity; Not using tobacco; Lack of history of hypercalcemia, nephrolitiasis or sarcoidosis; Lack of current pregnancy; Lack of recent history of hospitalization; Absence of liver or kidney disorder; current malignancy or malabsorption; Lack of immune suppression, or those drugs that will interfere with vitamin D metabolism, such as phenytoin and carbamazepine; Not taking vitamin D supplements meet; Lack of clinical bacterial vaginosis; Lack of normal amounts of vitamin D in first assessment; Detection of asymptomatic bacterial vaginosis with nugent test
Exclusion criteria: Unwillingness to continue the use of drug; pregnancy occurred; Drug allergy symptoms such as gastrointestinal symptoms; Vaginal infection symptoms like foul-smelling discharge; Use of drug non according to the pharmacist recommendation
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bacterial vaginosis. Timepoint: 105 days. Method of measurement: Nugent test.
- Secondary Outcome Measures
Name Time Method Concentration of vitamin D in serum. Timepoint: 105 days. Method of measurement: Lab test.